Metropolis Healthcare Ltd Peer Comparison - Competitive Analysis

Metropolis Healthcare Launches Centre of Genomics to Expand Precision Diagnostics in India

 Copy Link

Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years

Metropolis Healthcare Acquires Ambika Pathology for ₹17 Crore; Stock Rises 2.85%

 Copy Link

The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.

Metropolis Healthcare Reports 19% Drop in Q4 Net Profit

 Copy Link

The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.

Metropolis Healthcare Q3 Profit Rises 15.4% to ₹31.4 Crore

 Copy Link

The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.

Metropolis Acquires Core Diagnostics for ₹247 Crore to Boost Cancer Testing Expertise

 Copy Link

This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.

Top stocks for today - 11th November 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.

Top 10 stocks for today – 7th October 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.